MediWound Ltd. (MDWD)
$12.66-$0.58 (-4.38%) Today
Nachum Shamir - DirectorNachum Shamir - DirectorMediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 5 | 9,537 | $134K |
| Open-market sale | 3 | 5,823 | $75K |
| Option exercise | 2 | 16,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
4 Form 4 filings on record, the earliest from Jun 1, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Shmuel Hess - Officer | Open-market sale | Ordinary Shares | 1,865 | $13.00 | $24K | |
| Shmuel Hess - Officer | Open-market sale | Ordinary Shares | 1,979 | $12.72 | $25K | |
| Shmuel Hess - Officer | Open-market sale | Ordinary Shares | 1,979 | $13.13 | $26K | |
| Shmuel Hess - Officer | Option exercise | Stock Option (right to buy ordinary shares) | 5,000 | $0.00 | - | |
| Shmuel Hess - Officer | Option exercise | Stock Option (right to buy ordinary shares) | 11,000 | $0.00 | - | |
| Nachum Shamir - Director | Open-market purchase | Ordinary Shares | 175 | $13.98 | $2K | |
| Nachum Shamir - Director | Open-market purchase | Ordinary Shares | 5,825 | $14.00 | $82K | |
| David Morton Fox - Director | Open-market purchase | Ordinary Shares | 1,730 | $14.23 | $25K | |
| David Morton Fox - Director | Open-market purchase | Ordinary Shares | 10 | $14.23 | $142 | |
| David Morton Fox - Director | Open-market purchase | Ordinary Shares | 1,797 | $14.00 | $25K | |
| Samuel Rubinstein - Director | Open-market purchase | Ordinary Shares | 150 | $14.33 | $2K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Shmulik Hess | Officer | 3,958 | $50K | View on EDGAR |
MediWound Ltd. (MDWD) had 3 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for MDWD runs to 4 Form 4 filings, the earliest from 2026-06-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
5 insider purchases of MDWD were filed in the last 90 days, totaling $134K.
3 insider sales of MDWD were filed in the last 90 days, totaling $75K.
This page tracks MDWD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MDWD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$MDXHMDxHealth SA
$MEGINYLI CBRE Global Infrastructure Megatrends Term Fund
$MESOMESOBLAST LTD
$MEVOM Evo Global Acquisition Corp II
$MFBIMonroe Federal Bancorp, Inc.
$MFGMIZUHO FINANCIAL GROUP INC
$MFICMidCap Financial Investment Corp
$MFMABERDEEN MUNICIPAL INCOME FUND
$MFPMidera Food Processing, Inc.
$MFVMFS SPECIAL VALUE TRUSTEvery Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.